Obstetrics and gynaecology
Obstetrics and gynaecology
10-03-2022 | Oncology | News | Article
Cemiplimab OS advantage demonstrated for recurrent cervical cancer
The EMPOWER-Cervical 1 trial findings demonstrate a significant survival advantage with cemiplimab versus investigator’s choice of chemotherapy for women with recurrent or metastatic cervical cancer that has progressed after treatment with platinum-containing chemotherapy.
This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.
11-02-2019 | Oncology | News | Article
ART-conceived children not at increased risk for cancer
Children conceived using assisted reproductive technology do not have an increased cancer risk relative to either the general population or naturally conceived children of women with impaired fertility, shows a Dutch study with a long follow-up.